RXRA and schizophrenia: The current findings showing that expression of RXRA, PPARA and PPARB/D is abnormally reduced in the hair-follicle cells of patients with schizophrenia not only support their putative role in schizophrenia pathogenesis but also suggest that this measure is a potential biomarker for schizophrenia.